Deccan Health Care Ltd (DECCAN) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Deccan Health Care Ltd on NSE and BSE, with an AI summary of each filing.
Voting Result and Scrutinizer''s Report
Annual General Meeting · 01 Oct 2026, 4:31 pm
Deccan Health Care Shareholders Approve All Resolutions at 30th AGM Deccan Health Care Limited announced voting results for its 30th AGM held on 30th Sep'26. Shareholders approved all ordinary resolutions with 99.59% majority support (74,35,073 votes in favour vs 30,964 against). Key resolutions passed include the adoption of audited standalone and consolidated financial statements for FY26 and the reappointment of Mr. Umanja Venkata Satya Siva Srihari Kolla as director retiring by rotation. Overall voter turnout stood at 30.93% of the total 24,140,513 outstanding shares, with 100% promoter participation in favour.
Proceedings of 30th Annual General Meeting
Annual General Meeting · 30 Sept 2026, 7:27 pm
Annual Report for the FY 2025-26.
Others (Uncategorized) · 10 Sept 2026, 10:51 pm
Intimation
Annual General Meeting · 07 Sept 2026, 9:13 pm
Deccan Health Care Announces AGM, Book Closure, and E-Voting Dates Deccan Health Care will host its 30th Annual General Meeting on 30th Sep'26 at 12:00 PM via video conferencing. The company's Register of Members and Share Transfer books will remain closed from 24th Sep'26 to 30th Sep'26 (both days inclusive). The cut-off date to determine shareholder voting rights is set for 25th Sep'26. Remote e-voting opens on 27th Sep'26 at 09:00 AM IST and concludes on 29th Sep'26 at 05:00 PM IST for all transacted items.
Annual Report for the FY 2025-26.
Others (Uncategorized) · 07 Sept 2026, 9:11 pm
Notice of AGM
Annual General Meeting · 07 Sept 2026, 9:04 pm
Results
Financial Result · 14 Aug 2026, 7:45 pm
Deccan Health Care Q1FY27 Net Profit Rises 15.8% YoY Deccan Health Care reported consolidated results for the quarter ended 30th Jun'26, with revenue from operations down 0.3% YoY to ₹2,206.91 Lakhs. Profit Before Tax (PBT) grew 16.4% YoY to ₹38.85 Lakhs. Net Profit After Tax increased 22.8% YoY to ₹29.11 Lakhs, a significant improvement from the previous year. On a QoQ basis, revenue increased 5.2% while net profit declined by 12.8%. Basic EPS for the quarter stood at ₹0.12, up from ₹0.10 in the prior-year period.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find enclosed herewith the Un-Audited Financial Results (Standalone & Consolidated) ....
Outcome · 14 Aug 2026, 7:39 pm
Deccan Health Care Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 2,207 (-0.3% YoY | +5.2% QoQ) ■ EBITDA: 90.5 (+20.6% YoY | +1.6% QoQ) ■ EBITDA Margin (%): 4.1 (+71 bps YoY | -15 bps QoQ) ■ PAT: 29.1 (+22.8% YoY | -12.8% QoQ) ■ EPS (INR): 0.12 (+20.0% YoY | -14.3% QoQ)
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Un-audited Financial ....
Intimation · 14 Aug 2026, 5:30 am
Deccan Health Care Board Meeting Scheduled for Q1FY27 Results Deccan Health Care (BSE: 542248) has scheduled a Board of Directors meeting for 14th Aug'26. The primary agenda is to consider and approve the un-audited standalone and consolidated financial results for the first quarter ending 30th Jun'26. In line with insider trading regulations, the trading window for designated persons has been closed since 01st Jul'26 and will reopen 48 hours after the results are declared. This announcement was made to the BSE on 06th Aug'26.
Scrutinizer Report and Voting Results
Extra Ordinary General Meeting · 27 Jul 2026, 11:03 pm
Deccan Healthcare EGM: Shareholders Approve New Independent Director Appointments At its Extra-Ordinary General Meeting on 24-Jul'26, Deccan Healthcare Limited shareholders passed three special resolutions. The appointments of Mr. Bhupendra Singh Kataria, Ms. Pratiksha Bisht, and Ms. Manju Singh as Non-Executive Independent Directors were regularized. Each resolution received overwhelming approval, securing 99.96% of the total votes cast in favour. The promoter group voted 100% in favour, while public non-institutional shareholders voted 99.89% in favour for each appointment. Total voter turnout was 29.18% of outstanding shares.
Regularisation of Independent Directors
Change in Management · 24 Jul 2026, 9:39 pm
Deccan Healthcare Appoints Three Independent Directors to its Board Deccan Healthcare (BSE: 542248) announced that shareholders at its EGM on 24th Jul'26 approved the regularization of three Independent Directors: Mr. Bhupender Singh, Ms. Manju Singh, and Ms. Pratiksha Bisht. All three will serve a five-year term effective from 25th Apr'26. Mr. Singh, a retired government officer, joins the Audit Committee. Ms. Bisht will be a member of the Nomination and Remuneration Committee, and Ms. Manju Singh will join the Corporate Social Responsibility Committee. None hold shares in the company.
PROCEEDINGS OF EGM
Extra Ordinary General Meeting · 24 Jul 2026, 9:35 pm
Deccan Health Care Holds EGM to Appoint Three Independent Directors Deccan Health Care Limited held its 1st EGM for FY26 on 24 Jul'26 via video conference. Shareholders voted on three special resolutions to regularize the appointments of Mr. Bhupendra Singh Kataria, Ms. Pratiksha Bisht, and Ms. Manju Singh as Non-Executive Independent Directors. A total of 26 shareholders attended, including 2 from the promoter group and 24 public shareholders. The remote e-voting period was from 21 Jul'26 to 23 Jul'26. The results of the e-voting will be disclosed in due course.
Notice of EGM
Extra Ordinary General Meeting · 02 Jul 2026, 6:23 pm
Deccan Healthcare EGM to Approve Appointment of Three Independent Directors Deccan Healthcare has scheduled an Extra-Ordinary General Meeting (EGM) on 24-Jul'26 to seek shareholder approval for three board appointments. The special resolutions cover the regularization of Mr. Bhupendra Singh Kataria, Ms. Pratiksha Bisht, and Ms. Manju Singh as Non-Executive Independent Directors. Each director is proposed for a five-year term commencing from 25-Apr'26. The remote e-voting for these resolutions will be open from 21-Jul'26 to 23-Jul'26, with 17-Jul'26 set as the cut-off date for eligibility.
Appointment of Chief Financial Officer and Key Managerial Personnel of the Company.
Change in Management · 02 Jul 2026, 6:08 pm
Deccan Healthcare Appoints Tushar Mandal as New Chief Financial Officer Deccan Healthcare (BSE: 542248) appointed Mr. Tushar Mandal as Chief Financial Officer and Key Managerial Personnel, effective 02 Jul'26. The appointment was approved by the Board of Directors based on recommendations from the Nomination & Remuneration and Audit Committees. Mr. Mandal has been with the company for over eight years, managing its financial operations and functions. No relationships were disclosed between the new appointee and existing directors. The board meeting was held on 02 Jul'26, from 12:00 P.M. to 12:30 P.M.
Revised Resignation
Change in Management · 30 Jun 2026, 5:10 pm
Deccan Healthcare: Independent Director Bhavika Sanghani Resigns Deccan Healthcare announced the resignation of Independent Director Ms. Bhavika Sanghani (DIN: 10492381), effective 29-Jun-26. The company submitted a revised resignation letter confirming the reason as personal and unavoidable circumstances, with no other material reasons for the departure. Ms. Sanghani does not hold any directorships in other listed entities. The filing complies with SEBI's Regulation 30 disclosure requirements.
Resignation of Independent Director
Change in Management · 26 Jun 2026, 7:00 pm
Intimation
Change in Management · 26 Jun 2026, 6:39 pm
Cessation of Chief Financial Officer and Key Managerial Personnel of the Company.
Change in Management · 26 Jun 2026, 6:26 pm
Audited Standalone and Consolidated Financial results for the FY 2025-26.
Financial Result · 30 May 2026, 11:44 pm
Deccan Health Care FY26 Results: PAT Surges on Higher Revenue Deccan Health Care reported its audited standalone results for the quarter and year ended 31 Mar'26. For Q4FY26, revenue stood at ₹2,026.49 lakhs, with a net profit of ₹22.75 lakhs. On a full-year basis, FY26 revenue grew 18.7% YoY to ₹8,917.10 lakhs, while net profit surged 91.2% YoY to ₹229.04 lakhs. The board approved the financials, which received an unmodified opinion from the auditors. The FY26 basic EPS was ₹0.93 compared to ₹0.56 in FY25.
Annual Results for the FY 2025-26 and Corporate Update
Press Release · 30 May 2026, 11:17 pm
Deccan Healthcare FY26 Results: Strong Profitability Growth and Margin Expansion Deccan Healthcare reported strong FY26 results with consolidated Net Profit (PAT) surging 114.7% YoY to ₹248.76 lakhs. Consolidated revenue grew 9.1% YoY to ₹8,190.48 lakhs. Standalone performance was also robust, with revenue up 18.7% to ₹8,917.10 lakhs and PAT climbing 91.2% to ₹229.04 lakhs. Key standalone metrics showed significant growth, with EBITDA up 46.7% and EPS at ₹0.93, a 66.1% increase. Net profit margin expanded from 1.59% in FY25 to 2.57% in FY26, highlighting improved operational efficiencies.
Board of Directors of the Company, at its meeting held today i.e. Saturday, 30th May, 2026 which was commenced at 3:00 PM Via Video Conferencing, has inter alia considered and approved ....
Outcome · 30 May 2026, 9:42 pm
Deccan Health Care Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 2,098 (+1.1% YoY | +20.6% QoQ) ■ EBITDA: 89.1 (+47.2% YoY | -48.5% QoQ) ■ EBITDA Margin (%): 4.2 (+133 bps YoY | -570 bps QoQ) ■ PAT: 33.4 (+170.4% YoY | -66.7% QoQ) ■ EPS (INR): 0.14 (+180.0% YoY | -65.9% QoQ)
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Intimation · 30 May 2026, 5:30 am
Deccan Health Care Sets Board Meeting for Q4 & FY26 Results Deccan Health Care Ltd (BSE: 542248) has scheduled a Board of Directors meeting on Sat, 30 May'26 to consider and approve its audited standalone and consolidated financial results for the quarter and year ended 31 Mar'26. In line with insider trading regulations, the trading window for designated persons has been closed since 01 Apr'26 and will reopen 48 hours after the results are declared.
Intimation
Press Release · 30 Apr 2026, 10:11 pm
Deccan Healthcare Highlights Growth and Expansion into Sports Nutrition Deccan Healthcare Limited reports strong momentum in its Weight Wellness and Lifestyle portfolio, launched in Dec'25, which is significantly contributing to sales growth. The company is now expanding into the Hydration and Sports Nutrition segment. As part of its retail strategy, Deccan established 20 exclusive Wellness Marts (WM) in Q4 FY26 to enhance brand visibility and consumer engagement. The company plans to add another 30 Wellness Marts in Q1 of the current financial year to further scale its network.
Press Release
Press Release · 25 Apr 2026, 11:58 pm
Deccan Healthcare Reports Strong Wellness Growth, Expands into Sports Nutrition Deccan Healthcare reports strong momentum in its Weight Wellness and Lifestyle portfolio, launched in Dec'25, which is significantly contributing to sales growth. The company is expanding its retail footprint, having established 20 exclusive Wellness Marts in Q4 FY26, with plans to add 30 more in Q1 of the current financial year. Strategically, Deccan is developing a new product pipeline in the Hydration and Sports Nutrition categories to cater to performance-focused consumers, aligning with its science-led wellness vision.
Intimation
Change in Management · 25 Apr 2026, 11:55 pm
Deccan Healthcare Appoints New Company Secretary and Compliance Officer Deccan Healthcare Limited appointed Ms. Shikha Das as its Company Secretary and Compliance Officer, effective 25 Apr'26. Designated as Key Managerial Personnel, Ms. Das is an Associate Company Secretary with prior experience at a Maharatna Public Sector Undertaking. Her expertise covers corporate governance, regulatory compliance, and SEBI compliances. The company confirmed no relationships exist between Ms. Das and any current directors.